✦ LIBER ✦

Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes

✍ Scribed by Necchi, A.; Nicolai, N.; Mariani, L.; Raggi, D.; Fare, E.; Giannatempo, P.; Catanzaro, M.; Biasoni, D.; Torelli, T.; Stagni, S.; Milani, A.; Piva, L.; Pizzocaro, G.; Gianni, A. M.; Salvioni, R.

Book ID: 121343847
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 194 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt271

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1055 Modified cisplatin, etoposide and i

1055 Modified cisplatin, etoposide and ifosfamide (PEI) salvage therapy for male germ-cell tumors (GCT). Long-term efficacy and safety outcomes

✍ Necchi, A.; Mariani, L.; Nicolai, N.; Raggi, D.; Farè, E.; Giannatempo, P.; Piva 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 90 KB

747 MODIFIED CISPLATIN, ETOPOSIDE AND IF

747 MODIFIED CISPLATIN, ETOPOSIDE AND IFOSFAMIDE (PEI) SALVAGE THERAPY FOR MALE GERM-CELL TUMORS (GCT). LONG-TERM EFFICACY AND SAFETY OUTCOMES

✍ Necchi, Andrea; Mariani, Luigi; Giannatempo, Patrizia; Nicolai, Nicola; Raggi, D 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Cisplatin and ifosfamide with either vin

Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: The Institut Gustave Roussy experience

✍ Fadi Farhat; Stéphane Culine; Christine Théodore; Mohamed Békradda; Marie-Josée 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

## BACKGROUND. Approximately 30% of patients with metastatic germ cell tumors require salvage chemotherapy for recurrent or refractory disease after first-line treatment. The optimal salvage chemotherapy regimen remains to be determined. ## METHODS. Fifty-four patients with metastatic germ cell

Long-term results of a combination of pa

Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours

✍ Nicola Nicolai; Andrea Necchi; Luca Gianni; Luigi Piva; Davide Biasoni; Tullio T 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Long-Term Efficacy and Safety Outcomes o

Long-Term Efficacy and Safety Outcomes of Modified (Simplified) MVAC (Methotrexate/Vinblastine/Doxorubicin/Cisplatin) as Frontline Therapy for Unresectable or Metastatic Urothelial Cancer

✍ Necchi, Andrea; Mariani, Luigi; Giannatempo, Patrizia; Raggi, Daniele; Farè, Ele 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 358 KB

83 Long-term efficacy and safety outcome

83 Long-term efficacy and safety outcomes of the modified (simplified) combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) as front-line therapy for unresectable or metastatic urothelial cancer (UC)

✍ Necchi, A.; Mariani, L.; Giannatempo, P.; Raggi, D.; Fare', E.; Pizzocaro, G.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 70 KB